Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Metroglobal Limited Major Shareholding Notification 2019

Jun 8, 2019

59400_rns_2019-06-08_240b3275-530f-4482-939d-bda6501d3ae9.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

MEGHA BIOTECH PRIVATE LIMITED

(U24232GJ2007PTC051483)

Regd. Office: 401 B, Ratnamani Complex, Opp: Gandhi Gram Station, Nr. Nehru bridge,

Ahmedabad -380006

07/06/2019

To. BSE Limited P.J Towers, Dalal Street Fort, Mumbai - 400001

To, Company Secretary & Compliance Officer Metroglobal Limited (Target Company) 101, 1st Floor, "MangalDisha", Nr. Guru Gangeshwar Temple, 6th Road, Khar (West) Mumbai - 400052, Maharashtra, India.

Sub: Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Ref: Target Company: Metroglobal Limited (BSE code: 500159)

Dear Sir.

Please find attached herewith disclosures under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 in the prescribed format.

Kindly take the above documents on records and oblige.

Thanking you,

Yours Faithfully,

For Megha Biotech Private Limited

Hyan

Authorised Signatory

Encl: As above

MEGHA BIOTECH PRIVATE LIMITED

(U24232GJ2007PTC051483)

Regd. Office: 401 B, Ratnamani Complex, Opp: Gandhi Gram Station, Nr. Nehru bridge,

Ahmedabad -380006

Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name of the Target Company (TC) Metroglobal Limited
Name(s) of the acquirer and Persons Acting in
Concert (PAC) with the acquirer		 Megha Biotech Private Limited
Whether
belongs
the
acquirer
to
Promoter/Promoter group		 No
Name(s) of the Stock Exchange(s) where the
shares of TC are Listed		 BSE Limited
Details of the acquisition / disposal as follows Number % w.r.t.total
share/voting
capital
wherever
applicable(*)		 % w.r.t. total
diluted
share/voting
capital of the TC
$(**)$
Before the (Sale)under consideration, holding
of:
a) Shares carrying voting rights
Shares in the nature of encumbrance (pledge/
b)		 27,05,447 $16.57^{(s)}$ $16.57^{(s)}$
lien/non-disposal undertaking/ others)
c) Voting rights (VR) otherwise than by shares
d) Warrants/convertible
securities/any
other
instrument that entitles the acquirer to receive
shares carrying voting rights in the T C
(specify holding in each category)
e) Total $(a+b+c+d)$ 27,05,447 $16.57^{(s)}$ $16.57^{(s)}$
Details of acquisition/sale: 24,00,000 $14.70^{(5)}$ $14.70^{(5)}$
a) Shares carrying voting rights aequired/sold
b) VRs acquired /sold otherwise than by shares
c) Warrants/convertible
securities/any
other
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC
(specify
holding in
each
category)
n i
acquired/sold
d) Shares encumbered / invoked/released by the
acquirer
Total $(a+b+c+/-d)$
e)		 24,00,000 $14.70^{(s)}$ $14.70^{(s)}$
After the acquisition/sale, holding of:
Shares carrying voting rights
a)		 3,05,447 $2.48^{(#)}$ $2.48^{(#)}$
b) Shares encumbered with the acquirer
c) VRs otherwise than by shares

$\,$ I

瓷

$\frac{1}{x}$ Hydro

MEGHA BIOTECH PRIVATE LIMITED

(U24232GJ2007PTC051483)

Regd. Office: 401 B, Ratnamani Complex, Opp: Gandhi Gram Station, Nr. Nehru bridge,

Ahmedabad -380006

Warrants/convertible securities/any
$\mathbf{d}$
other
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC
(specify holding in each category) after
acquisition
e) Total $(a+b+c+/-d)$ 3,05,447 $2.48^{(#)}$ $2.48^{(#)}$
Mode of acquisition / sale (e.g. open market / off-
market / public issue / rights issue / preferential
allotment / inter-se transfer etc).		 Tender of Equity Shares in the Buy-back Offer of
Target Company
Date of acquisition / sale of shares / VR or date of
receipt ofintimation of allotment of shares,
whichever is applicable		 June 6, 2019
(being settlement date)
Equity share capital / total voting capital of the TC
before the said acquisition/sale		 Shares of ₹10 each ₹16,32,67,420 divided into 1,63,26,742 Equity-
Equity share capital/ total voting capital of the TC
after the said acquisition-/ sale		 ₹12,33,43,750 divided into 1,23,34,375 Equity
Shares of ₹10 each (subject to the extinguishment of
39,92,367 Equity Shares bought back)
Total diluted share/voting capital of the TC after
the said acquisition		 bought back) 1,23,34,375 Equity Shares of ₹10 each (subject to
the extinguishment of 39,92,367 Equity Shares
  • $(*)$ Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under the SEBI (LODR) Regulations.
  • Diluted share/voting capital means the total number of shares in the TC assuming full conversion $(**)$ of the outstanding convertible securities/warrants into equity shares of the TC.
  • Percentage is calculated based on the entire paid-up capital of the TC before the buy-back of $(\$)$ Equity Shares.
  • $($ #2) Percentage is calculated based on the paid-up capital of the TC post the buy-back of Equity Shares.

For Megha Biotech Private Limited

$H_{44}$ d

Authorised Signatory

Place: 07-06-2019 Date:Ahmedabad

More from Metroglobal Limited

Regulatory Filings 2026
Jul 7
Regulatory Filings 2026
Jun 26
Regulatory Filings 2026
Jun 9
Report Publication Announcement 2026
May 13
Interim / Quarterly Report 2026
May 11
Interim / Quarterly Report 2026
May 11
Interim / Quarterly Report 2026
May 11
Regulatory Filings 2026
May 9
Regulatory Filings 2026
May 1
Regulatory Filings 2026
May 1
View all filings →